Product Images Cisatracurium Besylate

This seems to be a visual representation of some numerical data indicating percentage changes. The text shows the labels "MAP" and "HR" indicating that there may be two different metrics being compared. The percentage values indicate changes which can be positive, negative or as high as 460% which may indicate a significant increase. However, without further context, it is difficult to interpret what the data represents.*

Cisatracurium Besylate Injection is a sterile and nonpyrogenic paralyzing agent used for intravenous injection. The package includes a 5 mL single-dose vial that contains 10 mg/5 mL (2 mg/mL) of the injection. As it can cause respiratory arrest, facilities for artificial respiration should always be available. It should be stored between 2°C to 8°C (36°F to 46°F) and protected from light. Use within 21 days of removal from the refrigerator, even if reused the refrigerator. Any package which has passed its expiration date should be discarded. This drug is manufactured by Somerset Therapeutics, LLC in India.*

This is a warning label for a drug called Cisatracurium Besylate Injection, which is a paralyzing agent that can cause respiratory arrest. It is only available under prescription and manufactured by Somerset Therapeutics LLC. The usual dosage is mentioned, and it should be stored at a specific temperature range and protected from light. A package insert contains prescribing information. There are 10 single-dose vials each with 5mL of medication available under NDC 70069-141-10. The text is partially readable, but there are misplaced characters and non-English characters, which may make it difficult to understand the complete details.*

This is a warning label for the drug Cisatracurium Besylate injection, USP. It advises facilities to have immediate access to artificial respiration as the medication may cause respiratory issues. The drug should be stored between 2°C to 8°C (36 to 46°F) and should not be frozen or exposed to light. It also contains information about the size of the vial which is 13.5 x 30mm.*

This is a warning label for an injection of Cisatracurium Besylate, which is a paralyzing agent used during medical procedures. The label warns that the drug can cause respiratory arrest and that facilities for artificial respiration must be immediately available. The usual dosage is not provided and the label states that it is for single use only. The manufacturer's contact information is also provided.*

Cisatracurium Besylate Injection is a non-pyrogenic injection used intravenously. However, it is a paralyzing agent that can lead to respiratory arrest. It is advised to have facilities available for artificial respiration. Each mL of the injection has cisatracurium equivalent to 13.38 mg cisatracurium besylate. The dosage should be taken as specified in the prescription. The injection should be stored at 20-25°C or 68-77°F and protected from light. The manufacturer of the injection is Somerset Therapeutics, LLC based in Florida. The text also includes product codes and warnings.*